Latest filing published 25 Jun 2026 for Rhythm Pharmaceuticals, INC..
Filing timeline
BuySaleInsider track record
Closed purchases
Not enough history yet: 1 closed purchase, at least 2 are needed.
Purchases by company
Since each purchase
- -68.4%Entry US$8.90 · Close at T+365 US$2.81
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Jennifer L. Good: trading record in brief
Jennifer L. Good discloses dealings in 4 companies, chiefly Trevi Therapeutics, Inc., Rhythm Pharmaceuticals, Inc. and Penwest Pharmaceuticals Co. Over a trading history stretching from 11 November 2009 to 23 June 2026, the count stands at 40 filings.
Both buying and selling appear: 2 purchases worth €111k, against 11 sales worth €4.1M. Taken together, the sales exceed the purchases by €4.0M. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. The rest of the record consists of 1 share grant and 23 option exercises.
Most recently, on 25 June 2026, the filings show an option exercise in Rhythm Pharmaceuticals, Inc. The clock since the last published purchase (13 May 2019) now reads 2,736 days. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. For comparison, the SEC allows two business days to file a Form 4. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Jennifer L. Good
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 4,712 sharesCommon StockSEC:0001104659-26-077862:0
- 4,000 sharesCommon StockSEC:0001104659-25-061712:0
- 5,263 shares@ US$6.586.1% of flowCommon StockSEC:0000950170-25-044436:1
- 5,263 shares@ US$1.439.0% of flowCommon StockSEC:0000950170-25-044436:0
- 9,250 shares@ US$21.373.4% of flowCommon StockSEC:0001104659-24-101365:1
- 7,501 shares@ US$18.992.5% of flowCommon StockSEC:0001104659-24-101365:2
- 31,751 shares@ US$52.4029.0% of flowCommon StockSEC:0001104659-24-101365:3
- 15,000 shares@ US$22.9349.8% of flowCommon StockSEC:0001104659-24-101365:0
- 4,305 shares@ US$21.371.6% of flowCommon StockSEC:0001104659-24-098941:1
- 1,736 shares@ US$18.990.6% of flowCommon StockSEC:0001104659-24-098941:2
- 18,300 shares@ US$4.151.3% of flowCommon StockSEC:0001104659-24-098941:3
- 37,241 shares@ US$50.4533.0% of flowCommon StockSEC:0001104659-24-098941:4
- 12,900 shares@ US$22.9343.2% of flowCommon StockSEC:0001104659-24-098941:0
- 4,219 shares@ US$3.032.2% of flowCommon StockSEC:0000950170-24-104804:1
- 1,840 shares@ US$1.430.5% of flowCommon StockSEC:0000950170-24-104804:2
- 1,840 shares@ US$3.041.0% of flowCommon StockSEC:0000950170-24-104804:3
- 4,219 shares@ US$1.437.0% of flowCommon StockSEC:0000950170-24-104804:0
- 3,863 shares@ US$3.022.0% of flowCommon StockSEC:0000950170-24-104061:1
- 10,981 shares@ US$1.432.7% of flowCommon StockSEC:0000950170-24-104061:2
- 10,981 shares@ US$3.025.7% of flowCommon StockSEC:0000950170-24-104061:3
- 40,277 shares@ US$1.439.9% of flowCommon StockSEC:0000950170-24-104061:4
- 40,277 shares@ US$3.1121.4% of flowCommon StockSEC:0000950170-24-104061:5
- 3,863 shares@ US$1.436.5% of flowCommon StockSEC:0000950170-24-104061:0
- 4,945 shares@ US$21.371.8% of flowCommon StockSEC:0001104659-24-094009:1
- 5,763 shares@ US$18.991.9% of flowCommon StockSEC:0001104659-24-094009:2
25 of 40 declarations
